Membrane-bound IL-15 co-expression powers a potent and persistent CD70-targeted TRuC T-cell therapy
IntroductionAlthough T-cell immunotherapies have been effective in the treatment of hematological malignancies, solid tumors have proven challenging due to the immunosuppressive microenvironment and lack of viable target antigens. The immune checkpoint…